The ROE as of November 2024 (TTM) for Reunion Neuroscience Inc. (REUN) is -148.88%

According to Reunion Neuroscience Inc.’s latest financial reports and current stock price. The company's current ROE is -148.88%. This represents a change of 299.61% compared to the average of -37.26% of the last 4 quarters.

Reunion Neuroscience Inc. (REUN) Historical ROE (quarterly & annually)

How has REUN ROE performed in the past?

The mean historical ROE of Reunion Neuroscience Inc. over the last ten years is -110.08%. The current -148.88% ROE has changed 35.25% with respect to the historical average. Over the past ten years (40 quarters), REUN's ROE was at its highest in in the September 2019 quarter at 0%. The ROE was at its lowest in in the December 2020 quarter at -72.90%.

Reunion Neuroscience Inc. (REUN) ROE by Quarter and Year

Discovering the peaks and valleys of Reunion Neuroscience Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Reunion Neuroscience Inc. (REUN) Average ROE

How has REUN ROE performed in the past?

The current ROE of Reunion Neuroscience Inc. (REUN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Reunion Neuroscience Inc. (REUN) ROE vs. Peers

How is REUN’s ROE compared to its peers?

Reunion Neuroscience Inc.’s ROE is greater than Braxia Scientific Corp. (-611.01%), greater than Oxford Nanopore Technologies plc (-43.29%), greater than Algernon Pharmaceuticals Inc. (-213.50%), less than Awakn Life Sciences Corp. (175.85%), less than Accustem Sciences Inc. (63.71%), greater than Nuvalent, Inc. (-28.83%), less than OKYO Pharma Limited (0.42%), greater than Oxford Cannabinoid Technologies Holdings Plc (-143.95%), less than Neurobiological Technologies, Inc. (0%), greater than Pharming Group N.V. (-8.09%), less than Health Sciences Group, Inc. (0%), less than MedMira Inc. (19.53%), greater than SAB Biotherapeutics, Inc. (-94.04%), greater than Senti Biosciences, Inc. (-91.09%), less than Cingulate Inc. (11.47%), less than Bellicum Pharmaceuticals, Inc. (153.34%), greater than Hillstream BioPharma, Inc. (-47249.59%),

Build a custom stock screener for Reunion Neuroscience Inc. (REUN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Reunion Neuroscience Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Reunion Neuroscience Inc. (REUN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Reunion Neuroscience Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.